Maurice, re: Non-Hodgkins Lymphoma News. CNBC biz tv's Joe Kernan talked about some research breakthroughs at Coulter Pharmaceuticals (cltr) re: moniclonal antibody drugs for Non-Hodgkins Lymphoma.
I imagine you don't get CNBC in NZ (although who knows, I think they do get it in London for example). If not, Joe Kernan is the sort of resident stocks editor/ ex broker/ who tracks down mini stories on stocks, etc. He has an evident love of the medical tech area, more than others. This story in particular he said wasn't really a stock story, though that was his excuse. It was a story about some rays of hope in a tough area. I immediately thought of you, though I wasn't sure I had matched up the diseases right...I wrote down re: Coulter, but had to go back and find your post, which I am responding to, to be sure that is what your son has.
PS, Joe Kernan is not at all a tout, and is I think relatively sensitive to being used to tout. This was clearly something he cared about. I wounder if he himself has a relative/friend/acquaintance.
Unfortunately I haven't found on the newswires the info Joe was referring to. Maybe be there tomorrow. I had the impression that it was an actual drug, though early in trials.
Since most of the worlds is less tough than the US re: trying experimental, early stage, drugs, maybe there is something you can work with. Here's a link:
sec.yahoo.com
Regards, Doug |
